Regular ArticleEvidence That Smokeless Tobacco Use Is a Gateway for Smoking Initiation in Young Adult Males☆
References (27)
- et al.
Smokeless use in a population of young adults
Addict Behav
(1999) - et al.
Characteristics of smokeless tobacco users seeking treatment
Addict Behav
(1999) - et al.
Adolescent smokeless tobacco incidence: relations with other drugs and psychosocial variables
Prev Med
(1987) - et al.
A comparison of smokeless tobacco and smoking practices of university varsity and intramural baseball players
Addict Behav
(1991) - et al.
Psychosocial correlates of adolescent smokeless tobacco use
Addict Behav
(1985) - et al.
The role of social influences and tobacco availability on adolescent smokeless tobacco use
J Adolesc Health
(1997) - et al.
The social image of smokeless tobacco use in three different types of teenagers
Addict Behav
(1988) - et al.
Nicotine addiction: a pediatric disease
J Pediatr
(1997) - et al.
Trends in smokeless tobacco use among men in four states, 1988 through 1993
Am J Public Health
(1996) Morb Mortal Wkly Rep
(1998)
Oral spit tobacco: addiction, prevention, and treatment
Nicotine Tobacco Res
A pinch or a pouch instead of a puff? Implications of chewing tobacco for addictive processes
Addict Behav
Nicotine addiction: implications for public health policy
Social Issues
Cited by (118)
Marketing exposure and smokeless tobacco use initiation among young adults: A longitudinal analysis
2019, Addictive BehaviorsCitation Excerpt :Increased use of smokeless tobacco is concerning since smokeless tobacco use is linked to oral cancer and gastro-intestinal disorders (Piano et al., 2010; U.S. Department of Health and Human Services, 2014; World Health Organization, 2007), and smokeless tobacco is frequently used concurrently with other tobacco products (i.e., dual/poly use), particularly conventional cigarettes (Cheng et al., 2017; Mantey, Creamer, Pasch, & Perry, 2018; Osibogun, Taleb, Bahelah, Salloum, & Maziak, 2018). Furthermore, smokeless tobacco use may undermine cigarette smoking cessation attempts (Kalkhoran, Grana, Neilands, & Ling, 2015; Parascandola, Augustson, & Rose, 2009) or act as a “gateway” to other tobacco use (Haddock, Weg, DeBon, et al., 2001; Soneji, Sargent, Tanski, & Primack, 2015; Tam, Day, Rostron, & Apelberg, 2015; Tomar, 2003). These direct and indirect consequences of smokeless tobacco use may ultimately increase the incidence of tobacco-related morbidity and mortality.
Tobacco product transition patterns in rural and urban cohorts: Where do dual users go?
2018, Preventive Medicine ReportsCitation Excerpt :Geographic factors can also influence social norms with regard to product preferences (Kasza et al., 2017). For example, dual use of cigarettes and SLT is prevalent in rural settings (Frost-Pineda et al., 2010); urban dual users may choose cigarettes (or small cigars) in combination with e-cigarettes (Haddock et al., 2001; Mejia et al., 2010). Wave 1 findings of the Population Assessment of Tobacco and Health (PATH) Cohort, a nationally representative sample of U.S. youth and adults, indicated that 27.6% of adults use at least one tobacco product (O'Connor, 2012).
From mundane medicines to euphorigenic drugs: How pharmaceutical pleasures are initiated, foregrounded, and made durable
2017, International Journal of Drug PolicyEpidemiology
2017, Oral, Head and Neck Oncology and Reconstructive SurgeryThe changing tobacco landscape: What dental professionals need to know
2016, Journal of the American Dental AssociationWithholding differential risk information on legal consumer nicotine/tobacco products: The public health ethics of health information quarantines
2016, International Journal of Drug Policy
- ☆
This paper was supported by a grant from the U.S. National Institutes of Health (HL-53478) awarded to the University of Memphis (R.C. Klesges, Principal Investigator). The views expressed in the article are those of the authors and are not the official policy of the U.S. Government, Department of Defense, or U.S. Air Force.
- 2
To whom requests for reprints should be addressed at Health Research Group, University of Missouri, Kansas City, 4825 Troost, Suite 124, Kansas City, MO 64110.